PR-104

DRUG2 trials

Sponsors

Proacta, Incorporated

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Phase 1

PR-104 in Treating Patients With Advanced Solid Tumors

CompletedNCT00349167

Proacta, IncorporatedUnspecified Adult Solid Tumor, Protocol Specific

Start: 2005-12-31End: 2007-06-30Updated: 2012-11-30

PR-104 and Docetaxel or Gemcitabine in Treating Patients With Solid Tumors

CompletedNCT00459836

Proacta, IncorporatedUnspecified Adult Solid Tumor, Protocol Specific

Start: 2007-02-28Updated: 2011-03-02

Related Papers

PR-104 a bioreductive pre-prodrug combined with gemcitabine or docetaxel in a phase Ib study of patients with advanced solid tumours.

2012-10-2545 citations